Minerva Surgical, a women’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), closed its IPO of 6.25 million shares at a public offering price of $12 per share. The aggregate gross proceeds to Minerva Surgical from the offering were $75 million. Read more.
Minerva Surgical Closes $75M IPO
